Advanced Renal Injury Diagnosis with ReLIA IFA Kits: NGAL, Cys-C, B2-MG, and MAU Biomarkers from Amindo Biologics
IntroductionEarly detection and precise diagnosis are critical in managing renal injury and preventing progression to chronic kidney disease (CKD) or end-stage renal failure. Traditional markers like serum creatinine have limitations in sensitivity and response time. To bridge this gap, innovative biomarkers such as NGAL, Cystatin-C (Cys-C), Beta-2 Microglobulin (B2-MG), and Microalbuminuria (MAU) have emerged as…
